IRIS
PORZIO, Giampiero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.424
EU - Europa 3.163
AS - Asia 3.091
SA - Sud America 514
Continente sconosciuto - Info sul continente non disponibili 116
AF - Africa 65
OC - Oceania 9
Totale 13.382
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.299
SG - Singapore 1.280
IE - Irlanda 703
CN - Cina 697
RU - Federazione Russa 633
IT - Italia 566
BR - Brasile 430
TR - Turchia 365
DE - Germania 344
HK - Hong Kong 316
VN - Vietnam 233
UA - Ucraina 190
GB - Regno Unito 172
SE - Svezia 147
FI - Finlandia 106
FR - Francia 105
CA - Canada 67
CZ - Repubblica Ceca 43
IN - India 40
NL - Olanda 38
PL - Polonia 38
BD - Bangladesh 32
MX - Messico 28
JP - Giappone 25
BE - Belgio 23
MA - Marocco 22
ZA - Sudafrica 22
AR - Argentina 17
EC - Ecuador 15
IQ - Iraq 15
ES - Italia 11
CO - Colombia 10
PK - Pakistan 10
PY - Paraguay 10
UZ - Uzbekistan 10
VE - Venezuela 10
ID - Indonesia 9
JM - Giamaica 9
PE - Perù 8
TN - Tunisia 8
IL - Israele 7
JO - Giordania 7
RO - Romania 7
AU - Australia 6
CL - Cile 6
HN - Honduras 6
PH - Filippine 6
RS - Serbia 6
AE - Emirati Arabi Uniti 5
KE - Kenya 5
MY - Malesia 5
PT - Portogallo 5
AT - Austria 4
AZ - Azerbaigian 4
BO - Bolivia 4
EU - Europa 4
LT - Lituania 4
NP - Nepal 4
BG - Bulgaria 3
DZ - Algeria 3
NZ - Nuova Zelanda 3
OM - Oman 3
SA - Arabia Saudita 3
UY - Uruguay 3
AL - Albania 2
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EG - Egitto 2
GP - Guadalupe 2
GT - Guatemala 2
HU - Ungheria 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
CH - Svizzera 1
CU - Cuba 1
CY - Cipro 1
DK - Danimarca 1
GY - Guiana 1
HR - Croazia 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
LY - Libia 1
MC - Monaco 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 13.270
Salva come PNG Salva come JPEG
Città #
Chandler 712
Jacksonville 705
San Jose 705
Dublin 703
Singapore 659
Dallas 548
Ashburn 489
Hong Kong 313
Santa Clara 256
Boardman 225
Council Bluffs 183
The Dalles 171
Izmir 156
Ann Arbor 141
New York 125
Wilmington 114
Nanjing 112
Beijing 103
Lawrence 102
Princeton 102
Milan 98
Moscow 89
Los Angeles 77
Ho Chi Minh City 76
San Mateo 72
Munich 60
Columbus 50
Bremen 49
Lauterbourg 49
São Paulo 46
Dearborn 43
Rome 43
Brno 42
Hanoi 41
Seattle 40
Shenyang 40
Nanchang 37
Helsinki 35
Amsterdam 33
Montreal 31
Warsaw 31
Woodbridge 28
Jinan 26
L'aquila 25
Tokyo 25
Atlanta 24
Brussels 23
Frankfurt am Main 23
Tianjin 23
Des Moines 21
Naples 21
Hebei 20
Mountain View 20
Verona 20
Düsseldorf 19
San Francisco 19
Chicago 18
Kunming 18
London 18
Phoenix 18
Stockholm 18
Brooklyn 17
Casablanca 17
Denver 17
Johannesburg 17
Miano 17
Assago 16
Dong Ket 16
Orem 16
Chennai 15
Hefei 15
Da Nang 14
Norwalk 14
Falkenstein 13
Ningbo 13
Philadelphia 13
Zhengzhou 13
Guangzhou 12
Haiphong 12
Jiaxing 12
Shanghai 12
Changsha 11
Florence 11
Mexico City 11
Brasília 10
Buffalo 10
Genoa 10
Hải Dương 10
Belo Horizonte 9
Nuremberg 9
Rio de Janeiro 9
Tashkent 9
Toronto 9
Boston 8
Fortaleza 8
Monza 8
Poplar 8
Querétaro 8
Tappahannock 8
Cagliari 7
Totale 8.597
Salva come PNG Salva come JPEG
Nome #
The supportive care task force at the University of L'Aquila: 2-years experience 223
Epidemiology and Characteristics of Episodic Breathlessness In Advanced Cancer Patients: An Observational Study 188
Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study 180
Does pain intensity predict a poor opioid response in cancer patients? 179
Tapentadol in cancer pain management: a prospective open-label study 162
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice 162
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index 161
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 160
Efficacy and safety of deep, continuous palliative sedation at home: A retrospective, single-institution study 158
Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study 157
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50% 156
Oncology together for L'Aquila: early resumption of integrated oncological activities after the earthquake 155
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement? 154
Haloperidol for the treatment of opioid addiction in advanced cancer patients: a case series 152
Pain evaluation and management: a survey of Italian radiotherapists 151
Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients 151
Gabapentin in the treatment of hiccups in patients with advanced cancer: a 5-year experience 150
The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A ‘hypothesis-generator’ study from clinical practice 150
Evaluation of second-line anti-VEGF after first-line anti-EGFR based therapy in RAS wild-type metastatic colorectal cancer: The multicenter “SLAVE” study 150
Age differences in the last week of life in advanced cancer patients followed at home 149
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients 149
Single-institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non-small cell lung cancer patients treated with first-line chemotherapy 146
Safety and Effectiveness of Intravenous Morphine for Episodic Breakthrough Pain in Patients Receiving Transdermal Buprenorphine 145
Switching from Transdermal Drugs: An Observational "N of 1" Study of Fentanyl and Buprenorphine 142
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events 141
What Is Known about Theragnostic Strategies in Colorectal Cancer 141
Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain-Barré Syndrome 140
Multimodality treatment in metastatic gastric cancer: From past to next future 140
Assessment and treatment of symptoms among italian medical oncologists 139
Efficacy of pregabalin in the management of cetuximab-related itch 139
Gabapentin in the treatment of severe sweating experienced by advanced cancer patients 139
Integrating oncology and palliative home care in Italy: the experience of the "L'Aquila per la Vita" Home Care Unit 139
Knowledge and Attitudes of Young Italian Medical Oncologists Toward the Approach and Treatment of Pain: No Changes, Despite the Law 139
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable 139
Apoptosis induced by oxaliplatin in human colon cancer HCT15 cell line 138
The frequency of alcoholism in patients with advanced cancer admitted to an acute palliative care unit and a home care program 138
Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors 138
First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience 136
Can malignant bowel obstruction in advanced cancer patients be treated at home ? 134
The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy 134
Breakthrough pain in oncology: A longitudinal study 134
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes 134
Fentanyl Buccal Tablet vs. Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Randomized, Crossover, Comparison Study 134
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management 134
Pain intensity as prognostic factor in cancer pain management 133
The PERSONS score: A new tool for cancer patients' symptom assessment in simultaneous care and home care settings 131
Hiccup in patients with advanced cancer successfully treated with gabapentin: report of three cases 131
Dosing fentanyl buccal tablet for breakthrough cancer pain: Dose titration versus proportional doses 130
Immune Checkpoint Inhibitors and Myasthenic Syndromes: A Case Report of a Metastatic Renal Cell Carcinoma Patient Treated With Nivolumab 130
Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians’ practice 128
Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A “hypothesis-generator” preliminary report 128
Sleep Disturbances in Patients with Advanced Cancer in Different Palliative Care Settings. 127
Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids 127
Pattern of symptoms and symptomatic treatment in adults and the aged population: A retrospective analysis of advanced cancer patients followed at home 126
Timed-flat infusion (TFI) 5-fluorouracil with irinotecan and oxaliplatin in pancreatic adenocarcinomas: A single institution experience with FIr/FOx regimen 126
Palliative radiotherapy in advanced cancer patients treated with immune‑checkpoint inhibitors: The PRACTICE study 125
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 124
The use of fentanyl buccal tablets for breakthrough pain by using doses proportional to opioid basal regimen in a home care setting 123
The effects of low doses of pregabalin on morphine analgesia in advanced cancer patients 123
The PERSONS score for symptoms assessment in simultaneous care setting: A pilot study 123
Palliative sedation in patients with advanced cancer followed at home: A systematic review 122
Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care: a national survey 121
Choice of chemotherapy schedules in elderly patients (> 75 years) with metastatic colorectal cancer (mcrc) according to comorbidity 121
Prognostic factors of survival in patients with advanced cancer admitted to home care 121
Cancer care after natural disaster: Different countries, similar problems 121
Pain Characteristics and Analgesic Treatment in an Aged Adult Population: A 4-Week Retrospective Analysis of Advanced Cancer Patients Followed at Home. 120
Effective analgesic score: a "marker" of the effects of chemotherapy on pain in advanced cancer patients? 119
How do cancer patients receiving palliative care at home die? A descriptive study 119
Timed-flat infusion of 5-fluorouracil with docetaxel and oxaliplatin as first-line treatment of gastroesophageal adenocarcinoma: A single institution experience with the FD/FOx regimen 119
Validation of the pap score in advanced cancer patients who are candidates for palliative chemotherapy 118
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study 118
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study 117
Physical Exercise and Quality of Life in Breast Cancer Survivors 115
Morphine in the treatment of incident pain triggered by vinorelbine infusion 115
Palliative care in advanced cancer patients: how and when? And where? 114
Home care for cancer patients after an earthquake: the experience of the "L'Aquila per la Vita" Home Care Unit 114
Tools for Identifying Cancer Pain of Predominantly Neuropathic Origin and Opioid Responsiveness in Cancer Patients 114
Palliative sedation in advanced cancer patients followed at home: A retrospective analysis 114
Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies. 113
Topical menthol for treatment of chemotherapy-induced peripheral neuropathy 113
Rapid resolution of refractory chemotherapy induced oral mucositis with platelet gel-released supernatant in a pediatric cancer patient: a case report 109
Palliative sedation in patients with advanced cancer followed at home: A prospective study 109
Palliative sedation at home: A medical act practicable everywhere 108
Tapentadol at medium to high doses in patients previously receiving strong opioids for the management of cancer pain 108
Orphan symptoms in advanced cancer patients followed at home 108
Integration between oncology and palliative care: A plan for the next decade? 108
Opioids applied topically to painful cutaneous malignant ulcers in a palliative care setting 107
Supporto nutrizionale 105
Clinical and psychometric validation of the BreSAS questionnaire for symptom assessment among breast cancer survivors 102
Re. “Awareness and consideration of malnutrition among oncologists: Insights from an exploratory survey” 101
Prognostic significance of P53 mutations in high risk node positive breast cancer patients 99
Emergencies in patients with advanced cancer followed at home 98
Is there a role for neurologist in an oncological home care team? 97
Opioid switching in patients with advanced cancer followed at home. A retrospective analysis 97
Pharmacokinetics in pelvic stop-flow infusion and hypoxic pelvic perfusion with and without hemofiltration. 97
Topical morphine in the treatment of painful ulcers 96
Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a web based online survey among Italian experts on supportive care in cancer 95
Pruritus in a patient with advanced cancer successfully treated with continuous infusion of granisetron 94
Tumori Ginecologici 94
"palliative" or "supportive": Is It Just a Matter of Word? 92
Totale 12.987
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.404
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.404
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022381 0 0 0 21 27 6 11 41 36 6 40 193
2022/20232.108 133 151 32 237 192 200 2 137 898 14 61 51
2023/2024452 63 24 22 48 37 114 3 33 1 25 16 66
2024/20252.361 60 35 169 131 356 203 370 173 475 110 165 114
2025/20264.068 225 430 375 512 401 326 617 128 377 489 159 29
2026/20271.236 124 126 346 640 0 0 0 0 0 0 0 0
Totale 13.382